Sportelli P. External Entity

Publications

Sort by

Selected publications

  • The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrestLeukemia. 2016 Information Resource GET IT

Other